iStent from Glaukos Approved for Treatment of Glaucoma In Combination With Cataract Surgery
June 26, 2012
We’ve previously blogged positively about the iStent from Glaukos.
Yesterday, the FDA announced that the iStent from Glaukos was approved as the first device for use in combination with cataract surgery to reduce intraocular pressure in adult patients with mild or moderate open-angle glaucoma and a cataract.
As the FDA’s press release explains, the iStent is a small titanium tube placed through the meshwork of tissue that creates an opening between the eye’s anterior chamber and Schlemm’s canal that allows fluid to drain, potentially decreasing intraocular pressure.
Click here for the full press release.
You might also enjoy...
- iStent With Phaco Gets Better Pressure Control Than Phaco Alone
- FDA Panel Recommends Glaukos iStent for Premarket Approval
- Will New Carbon Material Revolutionize Surgical Treatment of Glaucoma?
- Implantation of SOLX Gold Shunt into Supraciliary Space Controls Intraocular Pressure in Glaucoma Patients
- Trabecular Micro-Bypass Implant of Glaukos iStent With Phacoemulsification Helped Reduce IOP
Jump down to form below to submit your own comments